Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of October 15, 2026, SPRO trades at $1.14 with a market cap of $65.22M and a P/E ratio of 8.11. SPRO moved +0.89% today. Year to date, SPRO is -51.91%; over the trailing twelve months it is -54.62%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SPRO, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.14 |
| Market Cap | $65.22M |
| P/E Ratio | 8.11 |
| EPS | $0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.22 |
| 52-Week Low | $0.51 |
| Volume | 22.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $47.00M |
| Net Income | $7.38M |
| Gross Margin | 0.00% |
SPRO analyst coverage data. Average price target: $0.00.